Search by Drug Name or NDC

    NDC 51660-0939-53 Cetirizine Hydrochloride 10 mg/1 Details

    Cetirizine Hydrochloride 10 mg/1

    Cetirizine Hydrochloride is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Ohm Laboratories Inc.. The primary component is CETIRIZINE HYDROCHLORIDE.

    Product Information

    NDC 51660-0939
    Product ID 51660-939_2a87ee90-da59-4e35-9cda-27759ba080d4
    Associated GPIs 41550020100320
    GCN Sequence Number 017037
    GCN Sequence Number Description cetirizine HCl TABLET 10 MG ORAL
    HIC3 Z2Q
    HIC3 Description ANTIHISTAMINES - 2ND GENERATION
    GCN 49291
    HICL Sequence Number 006544
    HICL Sequence Number Description CETIRIZINE HCL
    Brand/Generic Generic
    Proprietary Name Cetirizine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Cetirizine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 10
    Active Ingredient Units mg/1
    Substance Name CETIRIZINE HYDROCHLORIDE
    Labeler Name Ohm Laboratories Inc.
    Pharmaceutical Class Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077498
    Listing Certified Through 2024-12-31

    Package

    NDC 51660-0939-53 (51660093953)

    NDC Package Code 51660-939-53
    Billing NDC 51660093953
    Package 300 TABLET in 1 BOTTLE (51660-939-53)
    Marketing Start Date 2007-12-27
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 161c4122-2c89-46e6-a6ae-db088087330d Details

    Revised: 5/2021